Drug intelligence / Profile preview

VAXXITEK HVT + IBD + ND

Development stage: Unknown
Lead developer: Boehringer Ingelheim
Modality: Vaccines & Immunotherapeutics
Administration: Subcutaneous, In Ovo

Overview

**VAXXITEK HVT + IBD + ND** is a live recombinant veterinary vaccine for poultry, utilizing a herpesvirus of turkeys (HVT) vector platform to express protective antigens from infectious bursal disease virus (IBDV VP2 gene) and Newcastle disease virus (NDV fusion gene from genotype VII velogenic strains). Developed by Boehringer Ingelheim, it provides 3-in-1 protection against Marek’s disease (MD), infectious bursal disease (IBD), and Newcastle disease (ND) via a single in ovo or subcutaneous administration in day-old chicks or 18-19-day embryos, offering early onset (e.g., 4-5 days for MD, 2 weeks for IBD) and long-duration immunity throughout susceptible periods, with safety comparable to standard HVT vaccines and added bacteriostatic (penicillin, streptomycin) and fungistatic (amphotericin B) agents.[1][2][5]

Brand names: VAXXITEK HVT + IBD + ND
Other names: Vaxxitek HVT+IBD+ND

Beyond the preview

Go deeper on VAXXITEK HVT + IBD + ND.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VAXXITEK HVT + IBD + ND.

Explore the full profile